The expression of CXCR3 has been observed in patients with primary invasive cutaneous melanomas and there is a significant association of CXCR3-positive tumor cell immunostaining with tumor thickness >1 mm[8]. This evidence concerns the gene CXCR3 and cutaneous melanoma.